samedan logo
 
 
spacer
home > pmps > summer 2002 > interphex 2002 - a dedicated pharmaceutical event
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Interphex 2002 - A Dedicated Pharmaceutical Event

This year we experienced the final Interphex show at the NEC, Birmingham. In 2004, there will be another show organised by Reed Exhibitions, but more about that later.


In comparison to previous Interphex events, this year's show appeared to be smaller but cosier - there were approximately 160 high quality exhibitors. Interphex, which is supported by the International Society of Pharmaceutical Engineers (ISPE) caters for everyone from researchers through to pack technologists.

There were some interesting exhibitions in the biotech area at this event. For example, Amersham Biosciences, whose products are used to uncover the function of genes and proteins for the discovery and development of drugs and for the manufacture of biopharmaceuticals; and Biopharma Group - a company providing technology and process equipment primarily for the pharmaceutical and biotech industries, including freeze-dryers and freeze-drying analytical equipment.

The organisers of Interphex said that despite cautious trading conditions in the marketplace and a further reduction in the number of potential visiting companies following continued industry consolidation, Interphex 2002 attracted similar visitor numbers to the previous event in 2000 when some 2,500 attended. Visitors included senior technical and commercial staff from Big Pharma, as well as the generic and contract sectors and the growing biotechnology industry. Consultant engineers were also present, keeping themselves up-to-date with the latest technologies and equipment.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Dr Patricia Lobo, Editor of PMPS
spacer
Dr Patricia Lobo
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Language Weaver now available for ServiceNow customers

RWS, the world’s leading provider of technology-enabled language, content management, and intellectual property services, has released a new Language Weaver Connector for ServiceNow
More info >>

White Papers

Clinical Trial Site Contracting: The Conservative, Progressive and Hybrid Models

DrugDev

For the last 20 years, pharmaceutical companies have turned to a variety of clinical outsourcing solutions to reduce costs and improve timelines, enabling them to focus on their core value of research and development. In today’s tightly competitive market, companies are constantly striving for ways to further cut costs and reduce study startup cycle times, while maintaining quality. One of the key cost factors in global R&D spending, estimated at around $102 billion per Kalorama market research, is the cost of conducting clinical trials. CRO’s, which account for about 30% of the total R&D spending, have risen to the challenge of the clinical, technical and administrative management of these trials. But some pharmaceutical companies question how much control to relinquish to vendor partners, especially in the legal arena, due to potential ramifications.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement